In Brief: FDA reform
This article was originally published in The Rose Sheet
Executive Summary
FDA reform: House hearings on FDA reform legislation are now targeted for May 1-2. A bill addressing foods sponsored by Rep. Scott Klug (R-Wis.), one of three FDA reform measures introduced March 29, would substitute the Delaney clause's zero-risk standard for food and color additives and animal drugs with a negligible, or de minimus, risk standard. In an analysis of the bill by Democratic staffers, the Delaney clause section is described as "highly controversial and...complicated." Supporters of the Senate FDA reform bill (S 1477), sponsored by Nancy Kassebaum (R-Kan.), hope to bring that bill to the Senate floor the first week in May...